+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Capricor Therapeutics - logo

Capricor Therapeutics focuses on the discovery, development, and commercialization of novel therapeutics primarily for the treatment of cardiovascular diseases. The company's development stage drug candidates for cardiovascular diseases include CAP-1002 and enderitide, which are in Phase II clinical trials. It is also developing Exosomes for the treatment of cardiovascular and non-cardiovascular diseases. The company was founded in 2005 and is headquartered in Beverly Hills, California.

From
From
Bone Marrow Transplant Rejection - Pipeline Review, H2 2020 - Product Thumbnail Image

Bone Marrow Transplant Rejection - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 797 Pages
  • Global
From
From
From
Duchenne Muscular Dystrophy Global Market Report 2023 - Product Thumbnail Image

Duchenne Muscular Dystrophy Global Market Report 2023

  • Report
  • July 2023
  • 275 Pages
  • Global
From
Musculoskeletal Collaboration and Licensing Deals 2016-2023 - Product Thumbnail Image

Musculoskeletal Collaboration and Licensing Deals 2016-2023

  • Report
  • October 2023
  • 250 Pages
  • Global
From
Cardiovascular Collaboration and Licensing Deals 2016-2023 - Product Thumbnail Image

Cardiovascular Collaboration and Licensing Deals 2016-2023

  • Report
  • October 2023
  • 300 Pages
  • Global
From
From
Duchenne Muscular Dystrophy - Pipeline Insight, 2022 - Product Thumbnail Image

Duchenne Muscular Dystrophy - Pipeline Insight, 2022

  • Clinical Trials
  • July 2022
  • 200 Pages
  • Global
From
From
From
From
From
Stem Cell Therapy Global Market Report 2023 - Product Thumbnail Image

Stem Cell Therapy Global Market Report 2023

  • Report
  • February 2023
  • 175 Pages
  • Global
From
Loading Indicator